Home Science Eczema treatment cuts risk of death from COVID-19, study suggests

Eczema treatment cuts risk of death from COVID-19, study suggests

34

A monoclonal antibody used to treat asthma and eczema can improve survival for patients with moderate to severe COVID-19, a clinical trial suggests.

Source: ScienceDaily.com